Vicarious Surgical Inc (RBOT)
0.38
+0.05
(+15.12%)
USD |
NYSE |
May 20, 16:00
0.38
0.00 (0.00%)
After-Hours: 17:29
Vicarious Surgical Cash from Operations (TTM): -58.19M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -58.19M |
| December 31, 2023 | -62.30M |
| September 30, 2023 | -69.34M |
| June 30, 2023 | -65.90M |
| March 31, 2023 | -65.01M |
| Date | Value |
|---|---|
| December 31, 2022 | -61.21M |
| September 30, 2022 | -52.56M |
| June 30, 2022 | -52.36M |
| March 31, 2022 | -43.92M |
| December 31, 2021 | -33.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-69.34M
Minimum
Sep 2023
-33.30M
Maximum
Dec 2021
-56.41M
Average
-59.70M
Median
Cash from Operations (TTM) Benchmarks
| Ekso Bionics Holdings Inc | -11.31M |
| Perspective Therapeutics Inc | -13.34M |
| Xtant Medical Holdings Inc | -13.02M |
| Asensus Surgical Inc | -60.39M |
| Catheter Precision Inc | -10.51M |